Simplex Trading
NAVB

Simplex Trading’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Simplex Trading’s Portfolio NAVB Stock Details NAVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,416
Closed -$4.53K – 10496
2023
Q1 		$7K Sell
28,416
-100
-0.4% -$29 ﹤0.01% 7883
2022
Q4 		$5K Buy
28,516
+9,500
+50% +$2.38K ﹤0.01% 8147
2022
Q3 		$4K Sell
19,016
-10,600
-36% -$4.94K ﹤0.01% 9029
2022
Q2 		$21K Buy
29,616
+25,367
+597% +$21.5K ﹤0.01% 7586
2022
Q1 		$3K Sell
4,249
-14,419
-77% -$13.2K ﹤0.01% 9794
2021
Q4 		$18K Buy
18,668
+5,489
+42% +$7.73K ﹤0.01% 8524
2021
Q3 		$23K Hold
13,179
– – ﹤0.01% 8338
2021
Q2 		$24K Buy
+13,179
New +$23.3K ﹤0.01% 8456
2021
Q1 		– Sell
-11,755
Closed -$27.5K – 10633
2020
Q4 		$25K Sell
11,755
-9,457
-45% -$22.3K ﹤0.01% 6844
2020
Q3 		$57K Buy
21,212
+2,476
+13% +$8.88K ﹤0.01% 5497
2020
Q2 		$73K Buy
+18,736
New +$35.8K ﹤0.01% 5140
2019
Q4 		– Sell
-2,000
Closed -$1.73K – 8465
2019
Q3 		$1K Buy
+2,000
New +$1.23K ﹤0.01% 7141
2019
Q2 		– Sell
-5
Closed -$10 – 8311
2019
Q1 		$0 Buy
+5
New +$15 ﹤0.01% 8311
2016
Q4 		– Sell
-150
Closed -$2.38K – 6924
2016
Q3 		$2K Buy
+150
New +$1.9K ﹤0.01% 5142
2016
Q1 		– Sell
-40
Closed -$770 – 6667
2015
Q4 		$1K Buy
+40
New +$1.39K ﹤0.01% 5146
2015
Q3 		– Sell
-1,020
Closed -$38.5K – 6566
2015
Q2 		$32K Buy
+1,020
New +$29.6K ﹤0.01% 2053
2015
Q1 		– Sell
-40
Closed -$1.35K – 5950
2014
Q4 		$2K Buy
+40
New +$1.1K ﹤0.01% 3895

Other funds holding NAVB

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return

Simplex Trading's NAVB Position: Q2 2023 in Review

Simplex Trading sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2023, closing a stake of 28,416 shares — an estimated $4.53K sold.

Simplex Trading first reported a position in NAVB in Q4 2014 and held it in 17 quarters. The position peaked at $73K in Q2 2020. 23 funds tracked by Wall St. Rank hold NAVB as of Q2 2023.

  • Simplex Trading reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2023 after selling out during the quarter.
  • Simplex Trading sold 28,416 Navidea Biopharmaceuticals Inc. shares in Q2 2023, an estimated $4.53K.
  • Simplex Trading first reported a position in Navidea Biopharmaceuticals Inc. in Q4 2014 and held it in 17 quarters.
  • Simplex Trading's Navidea Biopharmaceuticals Inc. position peaked at $73K in Q2 2020.
  • 23 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2023.

Based on Simplex Trading's 13F filing for Q2 2023, filed 4 Aug 2023.